{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:15:04Z","timestamp":1782126904616,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872889"],"award-info":[{"award-number":["81872889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074068"],"award-info":[{"award-number":["82074068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20181332"],"award-info":[{"award-number":["BK20181332"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.apsb.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T12:27:16Z","timestamp":1612960036000},"page":"1578-1591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase"],"prefix":"10.1016","volume":"11","author":[{"given":"Jie","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-7151","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.02.005_bib1","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1158\/0008-5472.CAN-19-0803","article-title":"Recent developments and therapeutic strategies against hepatocellular carcinoma","volume":"79","author":"Yarchoan","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2021.02.005_bib2","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1158\/0008-5472.CAN-17-3896","article-title":"SHP-1 acts as a tumor suppressor in hepatocarcinogenesis and HCC progression","volume":"78","author":"Wen","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2021.02.005_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.02.005_bib4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.02.005_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.02.005_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease","volume":"13","author":"Petersen","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2021.02.005_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2021.02.005_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Dong","year":"2013","journal-title":"Canc Cell"},{"key":"10.1016\/j.apsb.2021.02.005_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature13557","article-title":"Fructose-1,6-bisphosphatase opposes renal carcinoma progression","volume":"513","author":"Li","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.005_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1476-4598-12-110","article-title":"Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells","volume":"12","author":"Li","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2021.02.005_bib11","doi-asserted-by":"crossref","first-page":"43864","DOI":"10.1038\/srep43864","article-title":"Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.005_bib12","article-title":"Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.02.005_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/onc.2009.332","article-title":"Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis","volume":"29","author":"Liu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2021.02.005_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.02.005_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.tcb.2015.07.011","article-title":"The functions of microRNAs: mRNA decay and translational repression","volume":"25","author":"Iwakawa","year":"2015","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2021.02.005_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/jhg.2016.53","article-title":"MicroRNAs and liver disease","volume":"62","author":"Otsuka","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.apsb.2021.02.005_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","article-title":"MiR-221 overexpression contributes to liver tumorigenesis","volume":"107","author":"Pineau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.02.005_bib18","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1038\/srep20065","article-title":"Differentially expressed miRNAs in hepatocellular carcinoma target genes in the genetic information processing and metabolism pathways","volume":"6","author":"Thurnherr","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.005_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2017.10.043","article-title":"MiR21 drives resistance to heat shock protein 90 inhibition in cholangiocarcinoma","volume":"154","author":"Lampis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.02.005_bib20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human microRNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines","volume":"130","author":"Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.02.005_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol"},{"key":"10.1016\/j.apsb.2021.02.005_bib22","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","article-title":"Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans","volume":"90","author":"Marquez","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.apsb.2021.02.005_bib23","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.7150\/thno.35458","article-title":"Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/mTOR axis in metastatic pheochromocytoma\/paraganglioma","volume":"9","author":"Calsina","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2021.02.005_bib24","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21\u2217 in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.02.005_bib25","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARalpha expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.02.005_bib26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.02.005_bib27","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1038\/srep13474","article-title":"Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation","volume":"5","author":"Nakamura","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.005_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.isci.2018.11.029","article-title":"CellMinerCDB for integrative cross-database genomics and pharmacogenomics analyses of cancer cell lines","volume":"10","author":"Rajapakse","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2021.02.005_bib29","first-page":"6459","article-title":"LncRNA TATDN1 induces the progression of hepatocellular carcinoma via targeting miRNA-6089","volume":"23","author":"Shen","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.apsb.2021.02.005_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.30300","article-title":"DEAD box protein 5 inhibits liver tumorigenesis by stimulating autophagy via interaction with p62\/SQSTM1","volume":"69","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.02.005_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2018.08.021","article-title":"A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial\u2013mesenchymal transition and metastasis in breast cancer","volume":"437","author":"Zhang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.02.005_bib32","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160385","article-title":"Liver glucose metabolism in humans","volume":"36","author":"Adeva-Andany","year":"2016","journal-title":"Biosci Rep"},{"key":"10.1016\/j.apsb.2021.02.005_bib33","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","article-title":"Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma","volume":"4","author":"Ma","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.02.005_bib34","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41419-018-1165-x","article-title":"Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.02.005_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-016-0530-6","article-title":"Long noncoding RNAs in cancer: mechanisms of action and technological advancements","volume":"15","author":"Bartonicek","year":"2016","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2021.02.005_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2021.02.005_bib37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2021.02.005_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.02.005_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.02.005_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trecan.2018.11.003","article-title":"Gluconeogenesis in cancer: function and regulation of PEPCK, FBPase, and G6Pase","volume":"5","author":"Wang","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2021.02.005_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2019.10.012","article-title":"Fructose-1,6-bisphosphatase 2 inhibits sarcoma progression by restraining mitochondrial biogenesis","volume":"31","author":"Huangyang","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2021.02.005_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41388-018-0469-8","article-title":"The FOXC1\/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:49:04Z","timestamp":1761929344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2211383521000435"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.02.005","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}